NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-050-2007-2-US-07 MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma US DIV 13/595,192 Abandoned
NHLBI E-251-2009-0-US-04 Azicon Beam Polarization Devices US National Stage 13/581,107 9086509 Issued PDF
NIA E-049-2001-0-US-21 GLP-1, Exendin-4, Peptide Analogs And Uses Thereof US CON 13/594,313 8853160 Expired PDF
NIAID E-301-2009-0-US-03 RSV Immunogens, Antibodies and Compositions Thereof US National Stage 13/502,595 Abandoned
NCATS E-277-2012-0-US-01 Compositions And Methods For Treating Cancers US 61/692,843 Abandoned
NIDDK E-308-2006-3-US-02 Cross-Coupled Peptide Nucleic Acids For Detection Of Nucleic Acids Of Pathogens US CON 13/592,490 9156778 Issued PDF
NCI E-097-2010-0-US-06 Gene Sets For Detection Of Ultraviolet A Exposure And Methods Of Use Thereof US National Stage 13/580,832 8741561 Abandoned PDF
NCATS E-156-2012-0-US-01 Cancer Treatment by Combined Inhibition of Proteasome and Topoisomerase Activities US 61/692,560 Abandoned
NINR E-023-2010-0-US-03 Biomarkers For Acute Ischemic Stroke US National Stage 13/580,571 9200322 Issued PDF
NIDDK E-185-2012-0-US-01 IMAGING AND DIAGNOSTIC METHODS, SYSTEMS, AND COMPUTER-READABLE MEDIA US 61/692,191 Abandoned
NIAID E-246-2012-0-US-01 Engineered Anthrax Lethal Toxin For Targeted Delivery US 61/692,143 Abandoned
NCI E-198-2012-0-US-01 Mesothelin Domain-Specific Monoclonal Antibodies And Use Thereof US 61/691,719 Abandoned
NCI E-151-2011-0-US-02 Reduction Of TGFB Signaling In Myeloid Cells In The Treatment Of Cancer US ORD 13/589,769 9115371 Abandoned PDF
NCI E-048-2012-0-US-01 EXPRESSION OF PROTEIN-CODING AND NONCODING GENES AS PROGNOSTIC CLASSIFIER IN EARLY STAGE LUNG CANCER US 61/691,118 Expired
NIDDK E-231-2012-0-US-01 Capillary Viscometer And Multiscale Pressure Differential Measuring Device US 61/691,209 Abandoned
NCI E-289-2011-0-CA-05 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF CA National Stage 2844500 Issued
NCI E-289-2011-0-MX-08 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF MX National Stage MX/a/2014/001717 Issued
NCI E-289-2011-0-AU-12 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF AU National Stage 2012296425 Issued
NCI E-289-2011-0-PCT-02 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF PCT PCT PCT/US2012/051299 Expired
NCI E-289-2011-0-EP-14 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF EP National Stage 12824638.6 Pending
NCI E-289-2011-0-SG-09 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF SG National Stage 201400975-7 Pending
NCI E-052-2013-0-US-01 Use Of Argon As A Tissue Fixation Preservative US 61/684,204 Abandoned
NIDDK E-260-2012-0-US-01 Cyclopentane-Peptide Nucleic Acids For Qualitative And Quantitative Detection Of Nucleic Acids US 61/684,354 Abandoned
NIAID E-222-2012-0-US-01 USE OF P47 FROM PLASMODIUM FALCIPARUM (PFS47) OR PLASMODIUM VIVAX (PVS47) AS A VACCINE OR DRUG SCREENING TARGETS FOR THE INHIBITION OF HUMAN MALARIA TRANSMISSION US 61/684,333 Abandoned
NCI E-289-2011-0-CN-06 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF CN National Stage 201280051154.2 Pending
NCI E-289-2011-0-IN-10 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF IN National Stage 1981/DELNP/2014 Pending
NIA E-271-2006-0-US-04 METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF CANCER US DIV 13/587,515 10077296 Issued PDF
NIDDK E-067-2010-0-US-09 Inverse Agonists And Neutral Antagonists For The TSH Receptor US National Stage 13/579,251 9206154 Abandoned PDF
NIAID E-084-2010-0-US-03 Vaccine And Methods Of Use Against Strongyloides Stercoralis Infection US National Stage 13/575,987 9056068 Issued PDF
NIAID E-324-2005-3-US-04 CONFORMATIONALLY STABILIZED HIV ENVELOPE IMMUNOGENS US CON 13/585,700 8715686 Abandoned PDF
NIDDK E-116-2010-0-US-04 Chrysophaentin Antimicrobial Compounds That Inhibit FTSZ Protein US National Stage 13/578,803 8399689 Abandoned PDF
NICHD E-273-2010-0-US-02 A Sensitive And Robust Method To Characterize Cell Size Distributions From Magnetic Resonance Data US ORD 13/584,699 Abandoned
NIAID E-050-1997-1-US-18 METHOD AND DEVICE FOR DETECTING THE PRESENCE OF A SINGLE TARGET NUCLEIC ACID IN A SAMPLE US DIV 13/572,649 8563275 Abandoned PDF
NICHD E-168-2009-0-PCT-02 Spin Echo Sequences For Diffusion Weighted Imaging of Moving Media PCT PCT PCT/US2012/050303 Expired
NHLBI E-037-2011-0-US-01 Development Of A Novel HDL Based Hydrophobic Drug Delivery System Using Amphipathic Peptides US 61/682,057 Abandoned
NCI E-254-2005-2-IL-17 Codon Optimized IL-15 and IL-15R-Alpha Genes for Expression in Mammalian Cells IL DIV 221384 Issued
NCI E-215-2007-0-ES-15 Methods for determining a hepatocellular carcinoma subtype ES EP 12179595.9 Abandoned
NCI E-215-2007-0-DE-14 Methods for determining a hepatocellular carcinoma subtype DE EP 12179595.9 Abandoned
NIAID E-173-2004-1-US-11 Method for Using Adenoviral Vectors to Induce an Immune Response US CON 13/568,239 Abandoned
NHGRI E-055-2005-2-US-05 Methods And Use Of Farnesyl Transferase Inhibitors (FTIs) For Laminopathies, Cellular Aging, And Artherosclerosis US DIV 13/567,432 8691501 Abandoned PDF
NIA E-101-2010-0-US-03 Regulatory B Cells (TBregs) And Their Use US National Stage 13/577,226 9228171 Issued PDF
NCATS E-050-2012-0-US-01 Cyclodextrin For the Treatment of Lysosomal Storage Diseases US 61/679,668 Abandoned
NIAID E-202-2011-1-CN-03 PROTEASE-DEFICIENT BACILLUS ANTHRACIS CN National Stage 201280048638.1 Issued
NIAID E-202-2011-1-PCT-02 PROTEASE-DEFICIENT BACILLUS ANTHRACIS PCT PCT PCT/US2012/049321 Expired
NIAID E-189-2011-2-PCT-01 Treatment And Prevention Of Diseases Mediated By Microorganisms via Drug-Mediated Manipulation of the Eicosanoid Balance PCT PCT COMB PCT/US2012/049280 Expired
NIAID E-189-2011-2-IN-04 Treatment And Prevention Of Diseases Mediated By Microorganisms via Drug-Mediated Manipulation of the Eicosanoid Balance IN National Stage 238/MUMNP/2014 Abandoned
NIAID E-202-2011-1-EP-04 PROTEASE-DEFICIENT BACILLUS ANTHRACIS EP National Stage 12753853.6 Abandoned
NIAID E-189-2011-2-EP-03 Treatment And Prevention Of Diseases Mediated By Microorganisms via Drug-Mediated Manipulation of the Eicosanoid Balance EP National Stage 12746443.6 Abandoned
NIAID E-202-2011-1-IN-05 PROTEASE-DEFICIENT BACILLUS ANTHRACIS IN National Stage 1570/DELNP/2014 Abandoned
NIDA E-286-2015-0-US-01 Induction Of Highly Specific Antibodies To A Hapten But Not To A Carrier Peptide By Immunication US 61/633,996 Abandoned